Related Experiment Video
Updated: Jun 5, 2026
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Identification of methicillin-resistant Staphylococcus aureus-specific peptides for targeted photoantimicrobial
Rebecca V Vince1, Leigh A Madden, Cristina M A Alonso
1Postgraduate Medical Institute, The University of Hull, Room 512, Wolfson building, Cottingham Road, Hull, UK HU6 7RX.
Abstract:
The increasing prevalence of multi-drug resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), necessitates development of alternative modes of bacterial targeting which are not hindered by antibiotic resistance and minimise collateral damage. To achieve this, the FliTrx™ bacterially-displayed peptide library was panned against MRSA and randomly selected clones (n = 20) were DNA sequenced. One selected peptide was synthesised as both cyclic and linear constructs. Binding of the cyclic construct was observed by flow cytometry against isolates of MRSA whilst the linear construct showed low affinity. Low reactivity was observed with other Staphylococcal sp., gram-negative bacteria and human keratinocytes. The selected peptide was also cloned in-frame, within the thioredoxin gene into the pPROTet.E 6xHN vector for protein expression. A porphyrin photosensitiser (5-(4-isothiocyanatophenyl)-10,15,20-tris(4-N-methylpyridiniumyl)porphyrin trichloride) was conjugated to the recombinant protein and the in vitro cytotoxic effect of the resulting bioconjugate was determined against MRSA and other non-specific bacterial and mammalian cell lines. Photoantimicrobial chemotherapy (PACT) using the bioconjugate showed a 66% reduction in MRSA growth in comparison with non-irradiated cells. This work demonstrates the potential to isolate peptides with binding specificity against MRSA that can be used for targeted PACT, providing an effective alternative to antibody targeting.
Insights
Researchers developed a novel peptide targeting methicillin-resistant Staphylococcus aureus (MRSA). This peptide, when conjugated to a photosensitizer for photoantimicrobial chemotherapy (PACT), effectively reduced MRSA growth, offering a promising alternative to antibiotics.
Area of Science:
- Microbiology
- Biotechnology
- Drug Discovery
Background:
- Rising antibiotic resistance, particularly from methicillin-resistant Staphylococcus aureus (MRSA), demands new therapeutic strategies.
- Current treatments face limitations due to resistance and potential collateral damage to host tissues.
- Development of alternative bacterial targeting methods is crucial for effective infection control.
Purpose of the Study:
- To isolate and characterize peptides with specific binding affinity to MRSA.
- To develop a targeted photoantimicrobial chemotherapy (PACT) approach using these peptides.
- To evaluate the efficacy of the peptide-photosensitizer bioconjugate against MRSA in vitro.
Main Methods:
- Panning of a bacterially-displayed peptide library against MRSA to identify specific binders.
- Synthesis and characterization of cyclic and linear peptide constructs for binding affinity assessment.
- Expression of the selected peptide fused to thioredoxin and conjugation with a porphyrin photosensitizer.
- In vitro evaluation of the bioconjugate's cytotoxic effect on MRSA and control cell lines under irradiation.
Main Results:
- A specific peptide binder for MRSA was successfully isolated and synthesized.
- The cyclic peptide construct demonstrated specific binding to MRSA isolates, with low reactivity to other bacteria and human cells.
- The resulting peptide-photosensitizer bioconjugate achieved a 66% reduction in MRSA growth via PACT compared to non-irradiated controls.
- The study highlights the specificity and effectiveness of the targeted PACT approach.
Conclusions:
- Peptides with specific binding capabilities against MRSA can be effectively isolated using display library technology.
- Targeted PACT using peptide-photosensitizer bioconjugates presents a viable alternative to conventional antibiotic therapies.
- This approach offers a promising strategy for combating multi-drug resistant bacterial infections with minimized collateral effects.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
01:25Rapid Identification of Pathogens
01:25Mechanism of Antibiotic Resistance in MRSA